Statistical methods in oncology trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Hazard ratio
Log-rank test
Cochran-Mantel-Haenszel test
Odds ratio
Cox proportional-hazards model
Fisher exact test
Risk difference
Stratified log-rank test
All oncology trials
2,067 results
- Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLANE-PCIndependent statistical analysis of Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04848337).
- Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): Complete Statistical AnalysisIndependent statistical analysis of Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: Complete Statistical AnalysisIndependent statistical analysis of Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177810).
- Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results,…
- Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: Complete Statistical AnalysisIndependent statistical analysis of Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00165503).
- Ploidy and Stroma in Early Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ploidy and Stroma in Early Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03039595).
- PLUMIndependent statistical analysis of Post-Prandial Liver Glucose Metabolism in PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03041129).
- PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- PO-BADOIndependent statistical analysis of French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic Documentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- POCHARBIIndependent statistical analysis of Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- POD1UM-201Independent statistical analysis of the phase 2 POD1UM-201 study of retifanlimab in metastatic Merkel cell carcinoma, including trial design, objective response rate, statistical methodology, safety, interpretation, and limitations.
- POEMIndependent statistical analysis of POEM (Practice Of Embracing Each Moment) STUDY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03078608).
- POGOIndependent statistical analysis of Pediatric Cardiac Output Monitoring Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04465370).
- POINTIndependent statistical analysis of Pediatric Oncology Nutrition Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06175273).
- Polar Wand Carbon Dioxide Cryotherapy for Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Polar Wand Carbon Dioxide Cryotherapy for Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01477177).
- POLARIXIndependent statistical analysis of the POLARIX phase 3 trial evaluating polatuzumab vedotin with R-CHP versus R-CHOP in diffuse large B-cell lymphoma, including trial design, endpoints, statistical methodology, and interpretation.
- PolenIndependent statistical analysis of Preoperative Olaparib Endometrial Carcinoma Study (POLEN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506816).
- POLLYIndependent statistical analysis of ER Reactivation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02188745).
- Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.: primary endpoint results, effect estimate with confidence…
- Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions: Complete Statistical AnalysisIndependent statistical analysis of Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PORTEC-2An independent statistical analysis of PORTEC-2, a randomized phase 3 trial comparing external-beam radiation therapy with vaginal brachytherapy after surgery for stage I endometrial cancer.
- Positive Activities for Asian American Cancer Patients and Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Positive Activities for Asian American Cancer Patients and Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05203614).
- Positive Youth Development in the Metaverse: Complete Statistical AnalysisIndependent statistical analysis of Positive Youth Development in the Metaverse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05858593).
- Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Post Market Evaluation of Aer-O-Scope Visualization: Complete Statistical AnalysisIndependent statistical analysis of Post Market Evaluation of Aer-O-Scope Visualization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02926209).
- Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis: Complete Statistical AnalysisIndependent statistical analysis of Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- POWERIndependent statistical analysis of Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- POWER PIINCIndependent statistical analysis of Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01614210).
- Pre-op Rectal ChemoRad +/- Cetuximab: Complete Statistical AnalysisIndependent statistical analysis of Pre-op Rectal ChemoRad +/- Cetuximab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00527111).
- Pre-operative Treatment for Patients With Untreated Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pre-operative Treatment for Patients With Untreated Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03138720).
- Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody: Complete Statistical AnalysisIndependent statistical analysis of Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PrE0801Independent statistical analysis of NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- PrE1003Independent statistical analysis of Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRECISIONAn independent statistical analysis of the phase 3 PRECISION trial evaluating MRI-targeted biopsy and TRUS-biopsy for clinically significant prostate neoplasm.
- PREDICTIndependent statistical analysis of Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PrefHERIndependent statistical analysis of Participant Preference of Subcutaneous (SC) Versus Intravenous (IV) Herceptin (Trastuzumab) in Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer: primary endpoint results, effect estimate with confidence…
- PREHABIndependent statistical analysis of A Supervised Prehabilitation Program for Patients With Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05692323).
- PrehabIndependent statistical analysis of Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03853473).
- PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: Complete Statistical AnalysisIndependent statistical analysis of PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01781403).
- Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955394).
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft…
- Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preoperative Treatment With Cetuximab and/or IMC-A12: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment With Cetuximab and/or IMC-A12: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00957853).